1. Home
  2. PCLA vs ONCY Comparison

PCLA vs ONCY Comparison

Compare PCLA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

N/A

Current Price

$6.05

Market Cap

78.7M

ML Signal

N/A

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

N/A

Current Price

$0.41

Market Cap

80.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCLA
ONCY
Founded
2008
1998
Country
Japan
United States
Employees
N/A
N/A
Industry
Building Products
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.7M
80.5M
IPO Year
2024
2002

Fundamental Metrics

Financial Performance
Metric
PCLA
ONCY
Price
$6.05
$0.41
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $4.40
AVG Volume (30 Days)
1.0M
★ 1.1M
Earning Date
02-12-2027
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.37
52 Week High
$19.61
$1.30

Technical Indicators

Market Signals
Indicator
PCLA
ONCY
Relative Strength Index (RSI) 46.81 33.42
Support Level $6.10 N/A
Resistance Level $7.19 $0.89
Average True Range (ATR) 0.91 0.04
MACD -0.10 0.00
Stochastic Oscillator 6.08 23.92

Price Performance

Historical Comparison
PCLA
ONCY

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: